Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Solid Tumor × Taxes × Clear all

Sponsor

Conditions

Breast Neoplasms 51 Fallopian Tube Neoplasms 28 Ovarian Neoplasms 23 Carcinoma, Non-Small-Cell Lung 22 Triple Negative Breast Neoplasms 15 Pancreatic Neoplasms 12 Breast Neoplasms, Male 11 Lung Neoplasms 10 Brenner Tumor 10 Inflammatory Breast Neoplasms 7 Uterine Cervical Neoplasms 5 Endometrial Adenocarcinoma 5 Adenocarcinoma of Lung 5 Urinary Bladder Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Cholangiocarcinoma 4 Carcinoma, Ovarian Epithelial 4 Adenocarcinoma, Bronchiolo-Alveolar 4 Adenocarcinoma Of Esophagus 4 Pleural Effusion, Malignant 3 Pancreatic Adenocarcinoma 3 Neoplasms 3 Thymoma 2 Neurotoxicity Syndromes 2 Gallbladder Neoplasms 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinosarcoma 2 Breast Carcinoma In Situ 2

Interventions

Nivolumab 4 pertuzumab 2 pembrolizumab 2 durvalumab 2 Paclitaxel 2 Docetaxel 2 Capecitabine 2 ulocuplumab 1 tremelimumab 1 tazarotene 1 talazoparib 1 romiplostim 1 pexidartinib 1 pamiparib 1 onartuzumab 1 magrolimab 1 entrectinib 1 cobimetinib 1 atezolizumab 1 Sunitinib 1 Rifampin 1 Ramucirumab 1 Radiosurgery 1 N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 1 Midazolam 1 MK-4166 1 LY3022855 1 LY2510924 1 LY-2157299 1 Itraconazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡